PL216739A1 - - Google Patents

Info

Publication number
PL216739A1
PL216739A1 PL21673978A PL21673978A PL216739A1 PL 216739 A1 PL216739 A1 PL 216739A1 PL 21673978 A PL21673978 A PL 21673978A PL 21673978 A PL21673978 A PL 21673978A PL 216739 A1 PL216739 A1 PL 216739A1
Authority
PL
Poland
Application number
PL21673978A
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PL216739A1 publication Critical patent/PL216739A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL21673978A 1977-06-20 1978-06-20 PL216739A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77584 1977-06-20

Publications (1)

Publication Number Publication Date
PL216739A1 true PL216739A1 (fr) 1980-05-19

Family

ID=19728618

Family Applications (3)

Application Number Title Priority Date Filing Date
PL21673978A PL216739A1 (fr) 1977-06-20 1978-06-20
PL20776678A PL207766A1 (pl) 1977-06-20 1978-06-20 Sposob wytwarzania nowych pochodnych peptydowych
PL21674078A PL216740A1 (fr) 1977-06-20 1978-06-20

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL20776678A PL207766A1 (pl) 1977-06-20 1978-06-20 Sposob wytwarzania nowych pochodnych peptydowych
PL21674078A PL216740A1 (fr) 1977-06-20 1978-06-20

Country Status (18)

Country Link
EP (1) EP0000330B1 (fr)
JP (2) JPS549224A (fr)
AT (1) AT364095B (fr)
AU (1) AU525005B2 (fr)
CA (1) CA1139305A (fr)
DD (1) DD139257A5 (fr)
DE (1) DE2860893D1 (fr)
DK (1) DK275178A (fr)
ES (3) ES470961A1 (fr)
FI (1) FI781933A (fr)
GR (1) GR71681B (fr)
IE (1) IE46957B1 (fr)
IL (1) IL54950A (fr)
NO (1) NO148921C (fr)
NZ (1) NZ187611A (fr)
PL (3) PL216739A1 (fr)
PT (1) PT68188A (fr)
ZA (1) ZA783504B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014815A3 (fr) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Dérivés peptidiques, procédé pour leur préparation et intermédiaires, et compositions pharmaceutiques contenant un de ces composés
DE3485094D1 (de) * 1983-01-25 1991-10-31 Ciba Geigy Ag Neue peptidderivate.
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
EP0306912A3 (fr) * 1987-09-08 1989-07-05 Albany Medical College Ensemble immunogène capable de provoquer sélectivement la production d'anticorps et compositions pharmaceutiques l'utilisant.
DE4119856A1 (de) * 1991-06-17 1992-12-24 Hoechst Ag N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
ES2096064T3 (es) * 1991-12-19 1997-03-01 Ciba Geigy Ag Derivados del acido aminosulfonico y procedimiento para su obtencion.
AU666789B2 (en) * 1992-12-28 1996-02-22 Takeda Chemical Industries Ltd. 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
EP0604945A1 (fr) 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, dérivés, préparation et utilisation
EP0641776A3 (fr) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Dérivés de thioglycérol.
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
DE10048840A1 (de) * 2000-10-02 2002-04-11 Biotechnolog Forschung Gmbh Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
FR2816060A1 (fr) * 2000-10-27 2002-05-03 Pf Medicament Procede d'identification de nouvelles molecules se liant au recepteur lox et utilisation de ces molecules
EA014644B1 (ru) 2005-06-13 2010-12-30 Кливлэнд Биолабс Инк. Способы защиты от апоптоза с применением липопептидов
EP1909813A4 (fr) * 2005-07-25 2009-09-09 Therimunex Llc Diacylglycerides peptidyle
DE102016005550A1 (de) 2016-05-09 2017-11-09 Emc Microcollections Gmbh Adjuvans zur lnduzierung einer zellulären lmmunantwort
MX2020004742A (es) * 2017-11-06 2020-08-13 Crown Equip Corp Sistema de colocacion lateral de vehiculo industrial.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2706490A1 (de) 1976-02-20 1977-08-25 Ciba Geigy Ag Neue carbonsaeureester

Also Published As

Publication number Publication date
NO148921C (no) 1984-01-11
DE2860893D1 (en) 1981-11-05
FI781933A (fi) 1978-12-21
ZA783504B (en) 1979-06-27
ATA445178A (de) 1981-02-15
GR71681B (fr) 1983-06-21
NO782138L (no) 1978-12-21
IE46957B1 (en) 1983-11-16
ES470961A1 (es) 1980-03-01
PL216740A1 (fr) 1980-05-19
ES478717A1 (es) 1979-12-16
JPS549224A (en) 1979-01-24
JPS6372671A (ja) 1988-04-02
IL54950A (en) 1983-10-31
IL54950A0 (en) 1978-08-31
CA1139305A (fr) 1983-01-11
PT68188A (de) 1978-07-01
JPS6360760B2 (fr) 1988-11-25
AU3723078A (en) 1980-01-03
EP0000330A1 (fr) 1979-01-24
IE781227L (en) 1978-12-20
PL207766A1 (pl) 1979-11-19
NO148921B (no) 1983-10-03
JPS641466B2 (fr) 1989-01-11
EP0000330B1 (fr) 1981-08-05
ES478718A1 (es) 1979-12-16
AU525005B2 (en) 1982-10-14
NZ187611A (en) 1981-07-13
DD139257A5 (de) 1979-12-19
AT364095B (de) 1981-09-25
DK275178A (da) 1978-12-21

Similar Documents

Publication Publication Date Title
DE2848459C2 (fr)
DE2812872C2 (fr)
DE2834551C2 (fr)
FR2376716B1 (fr)
GR71681B (fr)
DE2731771C2 (fr)
DK140742C (fr)
DK384977A (fr)
DE2823605C3 (fr)
FR2371698B1 (fr)
FR2377089B1 (fr)
DE2702370C2 (fr)
DK141384C (fr)
DE2704442B2 (fr)
DE2737990C2 (fr)
BG25809A1 (fr)
BG24331A1 (fr)
BG25812A1 (fr)
BG25815A1 (fr)
BG25819A1 (fr)
BG25811A1 (fr)
BE868323A (fr)
BG25810A1 (fr)
BG25838A1 (fr)
BG25820A1 (fr)